Variant report

Variant	nsv911772
Chromosome Location	chr19:41985624-42066279
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1507)
CpG islands
(count:305)
Chromatin interactive
region (count:21)
LncRNA
region (count:41)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1507 , 50 per page) page: 1 2 3 4 5 6 7 ... 31

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:42048361-42048501	HepG2	liver:	n/a	n/a
2	ARID3A	chr19:41985894-41986022	K562	blood:	n/a	n/a
3	ARID3A	chr19:42044288-42044433	K562	blood:	n/a	n/a
4	ATF1	chr19:42037809-42038256	K562	blood:	n/a	n/a
5	ATF1	chr19:42046751-42046881	K562	blood:	n/a	n/a
6	ATF1	chr19:41985515-41985820	K562	blood:	n/a	n/a
7	ATF1	chr19:42034637-42034760	K562	blood:	n/a	n/a
8	ATF1	chr19:42032569-42032575	K562	blood:	n/a	n/a
9	ATF2	chr19:42041202-42042096	GM12878	blood:	n/a	n/a
10	ATF2	chr19:42057741-42058452	GM12878	blood:	n/a	n/a
11	ATF2	chr19:42037562-42038519	GM12878	blood:	n/a	n/a
12	ATF2	chr19:42058880-42059462	GM12878	blood:	n/a	n/a
13	ATF2	chr19:42055362-42056183	GM12878	blood:	n/a	n/a
14	ATF2	chr19:42041209-42041983	GM12878	blood:	n/a	n/a
15	ATF3	chr19:42007044-42007229	K562	blood:	n/a	n/a
16	BACH1	chr19:42048408-42048594	K562	blood:	n/a	n/a
17	BACH1	chr19:42048903-42048999	K562	blood:	n/a	n/a
18	BACH1	chr19:42016903-42017186	K562	blood:	n/a	n/a
19	BACH1	chr19:41985825-41985834	K562	blood:	n/a	n/a
20	BATF	chr19:42022723-42023153	GM12878	blood:	n/a	n/a
21	BATF	chr19:42037778-42038228	GM12878	blood:	n/a	n/a
22	BATF	chr19:42055692-42056029	GM12878	blood:	n/a	n/a
23	BATF	chr19:42027742-42028251	GM12878	blood:	n/a	n/a
24	BATF	chr19:42027836-42028322	GM12878	blood:	n/a	n/a
25	BATF	chr19:42041513-42041943	GM12878	blood:	n/a	n/a
26	BATF	chr19:42007315-42007464	GM12878	blood:	n/a	n/a
27	BCL11A	chr19:42022922-42023098	GM12878	blood:	n/a	n/a
28	BCL11A	chr19:42041523-42041834	GM12878	blood:	n/a	n/a
29	BCL11A	chr19:42041151-42041932	GM12878	blood:	n/a	n/a
30	BCL3	chr19:42016218-42016628	GM12878	blood:	n/a	n/a
31	BCL3	chr19:42016314-42016648	GM12878	blood:	n/a	n/a
32	BCL3	chr19:42041346-42042017	GM12878	blood:	n/a	n/a
33	BCL3	chr19:42016667-42016907	GM12878	blood:	n/a	n/a
34	BCLAF1	chr19:42058839-42059499	GM12878	blood:	n/a	n/a
35	BCLAF1	chr19:42037618-42038574	GM12878	blood:	n/a	n/a
36	BCLAF1	chr19:42027598-42028326	GM12878	blood:	n/a	n/a
37	BCLAF1	chr19:42041201-42042022	GM12878	blood:	n/a	n/a
38	BCLAF1	chr19:42055316-42056221	GM12878	blood:	n/a	n/a
39	BHLHE40	chr19:42041299-42041952	GM12878	blood:	n/a	n/a
40	BHLHE40	chr19:42048495-42048573	GM12878	blood:	n/a	n/a
41	BHLHE40	chr19:41986254-41986585	K562	blood:	n/a	n/a
42	BHLHE40	chr19:42028460-42028816	GM12878	blood:	n/a	chr19:42028587-42028603 chr19:42028585-42028601
43	BHLHE40	chr19:41985631-41985823	K562	blood:	n/a	n/a
44	BHLHE40	chr19:42022983-42023012	GM12878	blood:	n/a	n/a
45	BHLHE40	chr19:42058942-42059293	GM12878	blood:	n/a	n/a
46	BHLHE40	chr19:42007430-42007554	K562	blood:	n/a	n/a
47	BRCA1	chr19:42057929-42058234	GM12878	blood:	n/a	n/a
48	CBX3	chr19:42060178-42060444	K562	blood:	n/a	n/a
49	CBX3	chr19:41985547-41986099	K562	blood:	n/a	n/a
50	CBX3	chr19:42007176-42007860	HCT-116	colon:	n/a	n/a

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:42026012-42026062	AG10803	skin:	n/a
2	chr19:42007378-42007428	SKMC	muscle:	n/a
3	chr19:42027798-42027848	PANC-1	pancreas:	n/a
4	chr19:42028551-42028601	AG09309	skin:	n/a
5	chr19:42031482-42031532	HEEpiC	esophagus:	n/a
6	chr19:42007378-42007428	IMR90	lung:	fetal
7	chr19:42027798-42027848	AG09309	skin:	n/a
8	chr19:42031482-42031532	AG09309	skin:	n/a
9	chr19:42026012-42026062	HepG2	liver:	n/a
10	chr19:42007378-42007428	GM12891	blood:	n/a
11	chr19:42031482-42031532	HCF	heart:	n/a
12	chr19:42028551-42028601	HEK293	kidney:	embryo
13	chr19:42027798-42027848	LNCaP	prostate:	n/a
14	chr19:42028551-42028601	NHBE	bronchial:	n/a
15	chr19:42026012-42026062	AG09309	skin:	n/a
16	chr19:42007378-42007428	NHBE	bronchial:	n/a
17	chr19:42028551-42028601	BE2_C	brain:	n/a
18	chr19:42031482-42031532	A549	lung:	n/a
19	chr19:42031482-42031532	SK-N-SH	brain:	n/a
20	chr19:42031482-42031532	GM19239	blood:	n/a
21	chr19:42028551-42028601	BJ	skin:	n/a
22	chr19:42031482-42031532	HCPEpiC	choroid plexus:	n/a
23	chr19:42031482-42031532	K562	blood:	n/a
24	chr19:42031482-42031532	HepG2	liver:	n/a
25	chr19:42031482-42031532	GM06990	blood:	n/a
26	chr19:42027798-42027848	HCPEpiC	choroid plexus:	n/a
27	chr19:42031482-42031532	Caco-2	colon:	n/a
28	chr19:42027798-42027848	GM12891	blood:	n/a
29	chr19:42026012-42026062	ovcar-3	ovarian:	n/a
30	chr19:42007378-42007428	HEK293	kidney:	embryo
31	chr19:42026012-42026062	Hepatocyte	liver:	n/a
32	chr19:42031482-42031532	LNCaP	prostate:	n/a
33	chr19:42026012-42026062	HCF	heart:	n/a
34	chr19:42027798-42027848	GM06990	blood:	n/a
35	chr19:42031482-42031532	HPAEpiC	pulmonary alveolar:	n/a
36	chr19:42007378-42007428	Hepatocyte	liver:	n/a
37	chr19:42026012-42026062	K562	blood:	n/a
38	chr19:42028551-42028601	HIPEpiC	eye:	n/a
39	chr19:42026012-42026062	GM19239	blood:	n/a
40	chr19:42028551-42028601	ProgFib	skin:	n/a
41	chr19:42031482-42031532	SKMC	muscle:	n/a
42	chr19:42027798-42027848	HRCEpiC	kidney:	n/a
43	chr19:42031482-42031532	SK-N-SH_RA	brain:	n/a
44	chr19:42026012-42026062	AG04450	lung:	fetal
45	chr19:42031482-42031532	NHBE	bronchial:	n/a
46	chr19:42027798-42027848	AG10803	skin:	n/a
47	chr19:42031482-42031532	HUVEC	blood vessel:	n/a
48	chr19:42028551-42028601	NB4	blood:	n/a
49	chr19:42027798-42027848	NHBE	bronchial:	n/a
50	chr19:42026012-42026062	HL-60	blood:	n/a

(count:21 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:42031680..42033853-chr19:42037171..42039044,2	K562	blood:
2	chr19:41944280..41946189-chr19:42004239..42006678,2	K562	blood:
3	chr19:42031680..42033653-chr19:42037544..42040304,2	K562	blood:
4	chr19:42055107..42057086-chr19:42062207..42064223,3	K562	blood:
5	chr19:41955214..41955908-chr19:42043733..42044434,2	MCF-7	breast:
6	chr19:41944061..41946977-chr19:42000429..42002001,2	K562	blood:
7	chr19:41955014..41955888-chr19:42048054..42049030,2	K562	blood:
8	chr19:42032930..42034561-chr19:42036519..42039384,2	MCF-7	breast:
9	chr19:42036448..42038567-chr19:42052200..42053873,2	MCF-7	breast:
10	chr19:42044232..42044742-chr19:42076655..42077555,2	MCF-7	breast:
11	chr19:41920096..41922257-chr19:42065475..42067160,2	MCF-7	breast:
12	chr19:42048109..42049006-chr19:42076514..42077838,6	MCF-7	breast:
13	chr19:42065450..42067193-chr19:42070166..42071920,2	K562	blood:
14	chr19:41955066..41955972-chr19:42043125..42044734,10	MCF-7	breast:
15	chr19:41955365..41955940-chr19:42043884..42044391,2	K562	blood:
16	chr19:41945911..41947481-chr19:41988789..41990689,2	K562	blood:
17	chr19:42035785..42038762-chr19:42042099..42044984,2	MCF-7	breast:
18	chr19:41970790..41973417-chr19:42039173..42040939,2	K562	blood:
19	chr19:42048016..42049035-chr19:42076640..42077541,6	MCF-7	breast:
20	chr19:42055153..42057086-chr19:42062207..42063970,2	K562	blood:
21	chr19:42048044..42048836-chr19:42069540..42070426,2	K562	blood:

(count:41 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ATP5SL-1	chr19:42001210-42001335	NONHSAT066458
2	lnc-C19orf69-2	chr19:42058123-42058198	ENSG00000268027.1
3	lnc-CEACAM21-3	chr19:42038230-42038534	ENSG00000268355.1
4	lnc-ATP5SL-1	chr19:42000448-42001335	ENSG00000249527
5	lnc-ATP5SL-1	chr19:42006494-42006559	ENSG00000249527
6	lnc-C19orf69-2	chr19:42061580-42061621	ENSG00000268027.1
7	lnc-ATP5SL-1	chr19:42006494-42006554	ENSG00000267107.2
8	lnc-C19orf69-2	chr19:42060076-42060116	ENSG00000268027.1
9	lnc-C19orf69-2	chr19:42061580-42061832	ENSG00000268027.1
10	lnc-ATP5SL-1	chr19:42001210-42001335	NONHSAT066451
11	lnc-C19orf69-2	chr19:42057550-42057672	ENSG00000268027.1
12	lnc-ATP5SL-1	chr19:42001210-42001338	NONHSAT066459
13	lnc-ATP5SL-1	chr19:42006494-42006554	ENSG00000249527
14	lnc-C19orf69-2	chr19:42055888-42055920	ENSG00000268027.1
15	lnc-CEACAM21-3	chr19:42037786-42038237	ENSG00000268355.1
16	lnc-ATP5SL-1	chr19:42001210-42001335	ENSG00000267107.2
17	lnc-CEACAM21-2	chr19:42041702-42042145	ENSG00000270164.1
18	lnc-C19orf69-2	chr19:42061321-42061469	ENSG00000268027.1
19	lnc-CEACAM21-2	chr19:42041545-42043262	ENSG00000270164.1
20	lnc-ATP5SL-1	chr19:42006494-42006554	ENSG00000249527
21	lnc-CEACAM21-2	chr19:42041929-42041963	ENSG00000270164.1
22	lnc-ATP5SL-2	chr19:42057938-42058639	NONHSAT066473
23	lnc-ATP5SL-1	chr19:42006494-42006539	ENSG00000267107.2
24	lnc-C19orf69-2	chr19:42061321-42061469	ENSG00000268027.1
25	lnc-ATP5SL-1	chr19:42006494-42006554	NONHSAT066453
26	lnc-CEACAM21-3	chr19:42037647-42037935	ENSG00000268355.1
27	lnc-CEACAM21-2	chr19:42041860-42041963	ENSG00000270164.1
28	lnc-CEACAM21-2	chr19:42042960-42043266	ENSG00000270164.1
29	lnc-C19orf69-2	chr19:42051554-42051558	ENSG00000268027.1
30	lnc-C19orf69-2	chr19:42057550-42057864	ENSG00000268027.1
31	lnc-CEACAM21-2	chr19:42042960-42043264	ENSG00000270164.1
32	lnc-CEACAM21-2	chr19:42042076-42042145	ENSG00000270164.1
33	lnc-ATP5SL-1	chr19:42006494-42006538	NONHSAT066457
34	lnc-CEACAM21-2	chr19:42042963-42043266	ENSG00000270164.1
35	lnc-ATP5SL-1	chr19:42006494-42006545	NONHSAT066458
36	lnc-ATP5SL-1	chr19:42006494-42006540	NONHSAT066451
37	lnc-CEACAM21-2	chr19:42042090-42042145	ENSG00000270164.1
38	lnc-CEACAM21-3	chr19:42037566-42037693	ENSG00000268355.1
39	lnc-C19orf69-2	chr19:42055888-42055920	ENSG00000268027.1
40	lnc-C19orf69-2	chr19:42060076-42060116	ENSG00000268027.1
41	lnc-ATP5SL-1	chr19:42000448-42001335	ENSG00000267107.2

No data

Variant related genes	Relation type
ENSG00000270164	TF binding region
ENSG00000268355	TF binding region
ENSG00000268027	TF binding region
ENSG00000267107	TF binding region
CEACAM21	TF binding region
ENSG00000268034	TF binding region
PLEKHA3P1	TF binding region
ENSG00000270164	CpG island
ENSG00000268355	CpG island
ENSG00000268027	CpG island
ENSG00000267107	CpG island
CEACAM21	CpG island
ENSG00000268034	CpG island
PLEKHA3P1	CpG island
ENSG00000268027	chromatin interactions
ENSG00000268355	chromatin interactions
ENSG00000007129	chromatin interactions
ENSG00000248098	chromatin interactions
ENSG00000105341	chromatin interactions
TMED7	miRNA target sites
SPTBN1	miRNA target sites
CNN3	miRNA target sites
CHST11	miRNA target sites

Extended variants
information (count: 2648 )
Associated
traits (count: 68 )

Variant overlapped rSNPs/rCNVs (count:2648 , 50 per page) page: 1 2 3 4 5 6 7 ... 53

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs887391	chr19:41985624-41985625	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs370033473	chr19:41985637-41985638	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs184398955	chr19:41985639-41985640	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs144187574	chr19:41985641-41985642	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs587709032	chr19:41985644-41985645	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs587764601	chr19:41985686-41985687	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs189582932	chr19:41985689-41985690	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs587717430	chr19:41985701-41985702	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs148663927	chr19:41985738-41985739	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs587643335	chr19:41985770-41985771	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs887392	chr19:41985802-41985803	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
12	rs144365829	chr19:41985816-41985817	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs191203767	chr19:41985840-41985841	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs587716329	chr19:41985855-41985856	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs587612811	chr19:41985907-41985908	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs587646825	chr19:41985917-41985918	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs11673591	chr19:41985931-41985932	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs147827949	chr19:41985981-41985982	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs587602395	chr19:41985982-41985983	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs587671815	chr19:41985991-41985992	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs372684025	chr19:41986009-41986010	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs184878603	chr19:41986057-41986058	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs587604222	chr19:41986105-41986106	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs189293677	chr19:41986106-41986107	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs181580306	chr19:41986158-41986159	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs587684737	chr19:41986182-41986183	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs587764455	chr19:41986183-41986184	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs587637689	chr19:41986191-41986192	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs186782325	chr19:41986214-41986215	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs2079811	chr19:41986217-41986218	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
31	rs587627800	chr19:41986246-41986247	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs117788287	chr19:41986291-41986292	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs189675020	chr19:41986302-41986303	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs587614094	chr19:41986362-41986363	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs587693662	chr19:41986385-41986386	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs587770368	chr19:41986408-41986409	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs587646682	chr19:41986410-41986411	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs10401413	chr19:41986443-41986444	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs7245690	chr19:41986461-41986462	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs587652730	chr19:41986471-41986472	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs587705573	chr19:41986496-41986497	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs587625672	chr19:41986508-41986509	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs374319883	chr19:41986535-41986536	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs2316974	chr19:41986536-41986537	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
45	rs587739740	chr19:41986538-41986539	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs181149255	chr19:41986554-41986555	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs7245945	chr19:41986607-41986608	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs186296771	chr19:41986611-41986612	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs587692677	chr19:41986642-41986643	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs587729011	chr19:41986667-41986668	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:68)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	22522925	CNVD
early-passage human iPS cells	21368824	CNVD
Schizophrenia	18511947	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD

Chromatin state (count:1401 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41983000-41986400	Weak transcription	Spleen	Spleen
2	chr19:41983400-41986400	Flanking Active TSS	HUVEC	blood vessel
3	chr19:41984200-41986400	Active TSS	Ovary	ovary
4	chr19:41985000-41986200	Weak transcription	Left Ventricle	heart
5	chr19:41985000-41986600	Enhancers	Adipose Nuclei	Adipose
6	chr19:41985000-41986600	Weak transcription	Skeletal Muscle Male	skeletal muscle
7	chr19:41985200-41986800	Weak transcription	Lung	lung
8	chr19:41985400-41986000	Enhancers	Fetal Heart	heart
9	chr19:41985400-41986200	Flanking Active TSS	K562	blood
10	chr19:41985400-41986400	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
11	chr19:41985600-41986600	Weak transcription	Right Atrium	heart
12	chr19:41986200-41986400	Active TSS	Left Ventricle	heart
13	chr19:41986200-41986800	Enhancers	K562	blood
14	chr19:41986400-41986800	Enhancers	Spleen	Spleen
15	chr19:41986400-41987000	Flanking Active TSS	Left Ventricle	heart
16	chr19:41986400-41987000	Enhancers	HUVEC	blood vessel
17	chr19:41986400-41987400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
18	chr19:41986600-41986800	Bivalent Enhancer	Adipose Nuclei	Adipose
19	chr19:41986600-41987000	Enhancers	Right Atrium	heart
20	chr19:41986600-41987000	Enhancers	Right Ventricle	heart
21	chr19:41986600-41987200	Enhancers	Skeletal Muscle Male	skeletal muscle
22	chr19:41986800-41987000	Flanking Bivalent TSS/Enh	Adipose Nuclei	Adipose
23	chr19:41986800-41987400	Enhancers	Lung	lung
24	chr19:41986800-41988400	Weak transcription	Spleen	Spleen
25	chr19:41987000-41987200	Bivalent Enhancer	Adipose Nuclei	Adipose
26	chr19:41987000-41987200	Enhancers	Fetal Muscle Trunk	muscle
27	chr19:41987000-41988000	Weak transcription	Left Ventricle	heart
28	chr19:41987000-41988400	Weak transcription	Right Ventricle	heart
29	chr19:41987400-41987800	Weak transcription	Lung	lung
30	chr19:41987800-41988800	Enhancers	Lung	lung
31	chr19:41988000-41988200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
32	chr19:41988000-41988600	Enhancers	Left Ventricle	heart
33	chr19:41988400-41988600	Bivalent Enhancer	Placenta	Placenta
34	chr19:41988400-41988600	Enhancers	Right Ventricle	heart
35	chr19:41988400-41988600	Enhancers	Spleen	Spleen
36	chr19:41988400-41988800	ZNF genes & repeats	Esophagus	oesophagus
37	chr19:41988600-41992200	Weak transcription	Spleen	Spleen
38	chr19:41988800-41989400	Weak transcription	Lung	lung
39	chr19:41989400-41990200	Enhancers	Lung	lung
40	chr19:41989600-41989800	Bivalent Enhancer	Left Ventricle	heart
41	chr19:41992200-41992800	ZNF genes & repeats	Spleen	Spleen
42	chr19:41992600-41993200	ZNF genes & repeats	Lung	lung
43	chr19:41992800-42001800	Weak transcription	Spleen	Spleen
44	chr19:41993200-42000200	Weak transcription	Lung	lung
45	chr19:41998800-41999000	ZNF genes & repeats	Adipose Nuclei	Adipose
46	chr19:41999000-42001600	Weak transcription	Adipose Nuclei	Adipose
47	chr19:41999600-42000600	Weak transcription	Left Ventricle	heart
48	chr19:42000200-42001000	ZNF genes & repeats	Lung	lung
49	chr19:42000200-42005400	Enhancers	Breast Myoepithelial Primary Cells	Breast
50	chr19:42000600-42000800	Genic enhancers	Left Ventricle	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links